Revance Therapeutic (RVNC) PT raised to $40 at Piper Sandler following doc survey
Tweet Send to a Friend
(Updated - January 31, 2023 8:40 AM EST)
Piper Sandler analyst David Amsellem raised the price target on Revance ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst David Amsellem raised the price target on Revance ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
